Skip to content
Optionomics Free · No account needed

Earnings analysis · 10-Q

ADUS earnings analysis

Filed November 4, 2026 · Our reading of the company's report

The latest report

Addus delivered solid operating momentum in Q3 2026: revenue rose 7.0% year over year to $387.733 million and EPS of $1.83 exceeded consensus by $0.07, while adjusted EBITDA rose 13.5% to $51.249 million. Revenue…

Read full summary

Addus delivered solid operating momentum in Q3 2026: revenue rose 7.0% year over year to $387.733 million and EPS of $1.83 exceeded consensus by $0.07, while adjusted EBITDA rose 13.5% to $51.249 million. Revenue modestly missed estimates and the filing does not provide current-quarter gross margin, operating margin, free cash flow, or segment revenue data. The pending approximately $275 million AccentCare acquisition is the principal forward catalyst and risk, with regulatory, closing, integration, and financing considerations.

Read the original on SEC.gov

Gross and operating margin

How much of each revenue dollar the business keeps.

33% Gross margin Operating margin Nov 2022 Aug 2026

One point per quarterly or annual filing. Both margins are shares of that report's revenue.

How we read each report

Our analysis across the last few reports.

Read as bullish Read as bearish Nov 2022 Nov 2026

Our model's reading of each filing, not the share price or the market's reaction. Annual and quarterly reports each occupy one position.

Reported figures

Earnings per share
$1.83

What stood out

  • Revenue grew 7% year over year

    Revenue was $387.733 million, up approximately 2.8% from $377 million in Q2 2026 and 7.0% from $362 million in Q3 2025, although it was approximately $0.891 million below the $388.624 million consensus estimate.

  • EPS exceeded consensus

    Actual EPS was $1.83 versus the $1.76 consensus estimate, a $0.07 beat or approximately 4.0%. EPS increased from $1.49 in Q2 2026 and $1.24 in Q3 2025.

  • EBITDA growth outpaced revenue

    Adjusted EBITDA increased 13.5% to $51.249 million, indicating earnings growth outpaced the 7.0% year-over-year revenue increase.

  • Meaningful pending acquisition

    The company entered into an agreement to acquire AccentCare’s personal care division for approximately $275.0 million; the transaction is expected to add approximately $280 million of annualized revenue if completed.

  • Controls remained effective

    Management stated that disclosure controls and procedures were effective as of September 30, 2026, and reported no changes in internal control that materially affected or were reasonably likely to materially affect financial reporting during the quarter.

What to watch

  • AccentCare closing risk

    The AccentCare acquisition has an approximately $275.0 million purchase price and remains subject to regulatory approvals and other closing conditions. The company states it may fail to complete the transaction on time or at all and would still bear transaction costs if it does not close.

  • Integration and execution risk

    The company expects integration expenses and identifies potential unanticipated problems, expenses, liabilities, regulatory risks, and management distraction. The expected acquisition benefit of approximately $280 million in annualized revenue may therefore be delayed, reduced, or not realized.

  • Variable-rate debt exposure

    As of September 30, 2026, approximately $24.3 million was outstanding on the variable-rate credit facility. A 100-basis-point increase in variable rates would have reduced nine-month net income by $0.4 million, or $0.02 per diluted share; the company has no interest-rate hedges.

Management's outlook

No formal numeric EPS or revenue guidance was provided. The pending AccentCare acquisition is expected to add approximately $280 million of annualized revenue for an anticipated purchase price of approximately $275 million.

Earlier filings 4

10-Q · August 4, 2026

Addus delivered an 8.0% year-over-year increase in Q2 revenue to $377.417 million and expanded operating margin to 10.3% from 9.4%, with diluted EPS of $1.73. Personal care was the principal growth engine, while hospice…

10-Q · May 5, 2026

Addus HomeCare Corporation reported solid Q1 2026 results with revenue of $363.6 million and EPS of $1.62, marking an 18.1% and 4.128% increase from the prior year respectively. While operating income rose 11.7%, the…

10-K · February 24, 2026

Addus reported 2025 net service revenue of $1,422,530,000 versus $1,154,599,000 in 2024 (a $267,931,000 / +23.2% increase) and net income of $95,910,000 in 2025 versus $73,598,000 in 2024. Growth was driven by the…

10-Q · May 7, 2024

Addus reported revenue of $280.7M for the quarter ended March 31, 2024, up $29.1M (+11.6%) versus the prior-year quarter, with gross profit rising to $88.2M and operating income to $23.6M. Diluted EPS increased to $0.97…

This is our reading of a public filing, not the filing itself. Analysis can contain errors; check the source document for full context.